Last checked at 
(Adds details)
GENEVA, April 22 (Reuters) - Technical experts from the
World Health Organization are due to start the next round of
their review of Russia's Sputnik V vaccine against COVID-19
jointly with the European Medicines Agency on May 10, the WHO
said on Thursday.
Russia is seeking WHO emergency-use listing for the vaccine
developed by Gamalaya Institute. So far COVID-19 vaccines made
by Pfizer AstraZeneca and Johnson & Johnson
have been listed - an endorsement of their safety and
efficacy that helps guide countries' regulatory systems.
"Inspections for good manufacturing practices will take
place from 10 May to 1st week of June," the WHO told Reuters in
reply to a query.
A joint team from the WHO and EMA are currently carrying out
inspections for good clinical practices related to Sputnik, it
said.
Asked about clinical data from Sputnik vaccine trials, the
WHO said: "We are still receiving information from the
producer."
Russian deputy health minister Sergei Vershinin held talks
in Geneva on Tuesday with WHO director-general Tedros Adhanom
Ghebreyesus, who later wrote on Twitter: "@WHO appreciates
Russia's efforts to fulfill the Emergency Use Listing criteria
for vaccines".
(Reporting by Stephanie Nebehay; Editing by Gareth Jones and
Hugh Lawson)
